LGMAX
Price
$24.78
Change
+$0.15 (+0.61%)
Updated
Jan 17 closing price
Net Assets
2.94B
RIRBX
Price
$70.01
Change
+$0.35 (+0.50%)
Updated
Jan 17 closing price
Net Assets
106.93B
Ad is loading...

LGMAX vs RIRBX

Header iconLGMAX vs RIRBX Comparison
Open Charts LGMAX vs RIRBXBanner chart's image
Loomis Sayles Global Allocation A
Price$24.78
Change+$0.15 (+0.61%)
VolumeN/A
Net Assets2.94B
American Funds Capital Income Bldr R2
Price$70.01
Change+$0.35 (+0.50%)
VolumeN/A
Net Assets106.93B
LGMAX vs RIRBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGMAX vs. RIRBX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGMAX is a Hold and RIRBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 107B vs. LGMAX (2.94B). RIRBX pays higher dividends than LGMAX: RIRBX (2.55) vs LGMAX (0.14). LGMAX was incepted earlier than RIRBX: LGMAX (19 years) vs RIRBX (23 years). RIRBX is a more actively managed with annual turnover of: 106.00 vs. LGMAX (19.00). RIRBX has a lower initial minimum investment than LGMAX: RIRBX (250) vs LGMAX (2500). RIRBX annual gain was more profitable for investors over the last year : 9.89 vs. LGMAX (9.13). RIRBX return over 5 years is better than : 19.51 vs. LGMAX (-0.36).
LGMAXRIRBXLGMAX / RIRBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years23 years-
Gain YTD2.3541.405168%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.94B107B3%
Annual Yield % from dividends0.142.555%
Returns for 1 year9.139.8992%
Returns for 3 years-5.535.65-98%
Returns for 5 years-0.3619.51-2%
Returns for 10 years38.3930.09128%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTCT43.840.76
+1.76%
PTC Therapeutics
CBAN15.840.22
+1.41%
Colony Bankcorp Inc
ABCL2.970.03
+1.02%
AbCellera Biologics
PAVM0.650.01
+0.81%
PAVmed
EXPE187.28-1.39
-0.74%
Expedia Group